The Equity Supply Inflection: What $700 Billion in New Shares Means for 2026 and 2027

For 23 years, the U.S. stock market has been shrinking. Buybacks, going-private transactions, and minimal IPO activity have steadily retired more shares than new listings created. That era is ending in 2026. Goldman Sachs estimates net U.S. equity issuance will be roughly flat this year—the first time since 2003 that new supply won’t be negative^[1]. By 2027, as lockup periods on this year’s record IPO cohort expire, the bank expects net supply to turn decisively positive^[1].

The inflection is not a single event but a convergence of three forces: a record IPO wave, the staggered unlocking of SpaceX’s massive insider base, and the abrupt halt of buybacks at one of the market’s largest companies. Whether public markets can absorb this supply without material multiple compression is the structural question hanging over the second half of 2026 and all of 2027.

The IPO Wave by the Numbers

H1 2026 was one of the most active periods for new equity issuance on record. U.S. IPOs and share sales surpassed $251 billion, the highest first-half total since the 2021 boom, spread across more than 200 announced listings^[2]. Nasdaq reported its strongest first half in exchange history^[2]. The Federal Reserve separately recorded $389 billion in new stock issuance in Q1 alone, the second-largest quarterly total in records dating to 1996^[3].

By midyear, roughly 50 U.S. IPOs had priced—about double the same point in 2025—and dollar volume of roughly $120 billion already tied the full-year 2021 record^[4]. Goldman Sachs forecasts that combining IPOs with follow-on offerings will produce approximately $700 billion in total equity supply for the full year^[4].

Yet scale alone does not make a bubble. Goldman’s chief U.S. equity strategist Ben Snider notes that the 25-year average runs about 100 deals per year, and 2026 is tracking near that norm. By contrast, 2021 saw over 250 IPOs and 1999 nearly 400^[4]. The current surge is defined by a small number of very large deals, not a broad frenzy of low-quality issuers.

H1 2026 IPO Cohort: Key Listings

Sources: EquiLend DataLend research^[2].

The $700 billion supply figure sounds large, but it scales to roughly 1% of the total U.S. equity market—actually below the long-term historical average and in line with the 2015–2019 environment^[4]. Meanwhile, corporate buybacks are expected to exceed $1 trillion this year, meaning corporate demand alone should outweigh corporate supply in 2026^[4].

The math, however, gets harder in 2027.

SpaceX: The $123 Billion Unlock Calendar

No single company encapsulates the supply question like SpaceX. The June 12 IPO raised $86.2 billion at $135 per share, valuing the company at $1.77 trillion—more than three times the previous record set by Saudi Aramco in 2019^[2]. The stock surged to approximately $201 shortly after listing before grinding lower. By late July, it had fallen to about $131, an all-time low and below the $135 offer price^[5].

The securities lending story has been equally dramatic. Shares on loan expanded from 18.6 million on June 15 to over 211 million by July 10—an elevenfold increase in under four weeks—with on-loan value reaching approximately $30.7 billion^[2]. Short sellers who established positions near the post-IPO peak have broadly been right.

SpaceX’s $86.2B June listing at a $1.77T valuation entered public markets more than three times larger than any prior IPO in history.

The lockup structure is unusually complex, and it is the calendar for the remainder of 2026 that poses the real absorption test:

SpaceX Lockup Unlock Schedule

Sources: EquiLend^[2], finbold^[5], scanx.trade^[5].

The conditional tranche is almost certainly off the table—SpaceX has been trading below its $135 IPO price, not 30% above it. But the 20% unlock on August 6 alone releases roughly $123 billion in newly tradable shares^[5]. That is the single largest lockup expiration in market history, and it arrives just two days after the company’s first public earnings report on August 4^[5].

An ex-Nasdaq CEO has warned that the full extended-investor block, including Musk’s position, could ultimately represent as much as $800 billion in locked shares that will eventually enter the float^[6]. Most of that is gated until 2027, but the staggered tranches through October will provide incremental supply pressure every few weeks.

Alphabet’s Buyback Halt: The Demand Side Shifts

While new supply surges on one side, a pillar of demand is weakening on the other. Alphabet ended a 33-quarter buyback streak in 2026, repurchasing zero shares in both Q1 and Q2, compared with $28.31 billion in the first half of 2025^[7]. The halt was not caused by an exhausted authorization—a sizable balance remained available^[7].

The cause is capital expenditure. Quarterly capex rose from $27.85 billion in Q4 2025 to $44.92 billion in Q2 2026, exceeding operating cash flow and pushing free cash flow to negative $5.86 billion^[7]. Alphabet raised $49.6 billion in equity and $20.3 billion in debt in Q2 alone, nearly doubling long-term debt to $98.2 billion in six months^[7]. The company raised its 2026 capex outlook to $195–$205 billion^[7].

Alphabet’s AI infrastructure spending pushed quarterly capex to $44.9B, exceeding operating cash flow and forcing the first quarterly cash burn since the company went public.

This makes Alphabet a net issuer of stock for the first time in 11 years^[1]. Prior to 2026, the company had repurchased $45.71 billion in 2025, $62.22 billion in 2024, and $61.5 billion in 2023—buybacks that steadily reduced share count and provided a recurring source of demand^[7]. That demand has now gone to zero.

Fidelity’s Jurrien Timmer has argued that the broader buyback era—a key driver of the secular bull market since 2009—may be coming to an end as corporate repurchases decline across the market^[3]. The bifurcation is visible at the sector level: Financials are leading in share-count reduction, while Technology has shifted into net dilution^[3].

If Alphabet’s pattern spreads to other mega-cap technology companies funding AI infrastructure at similar scale, the $1 trillion buyback cushion that Goldman expects to absorb 2026’s supply could thin materially in 2027.

Is This a Bubble? Goldman Says Not Yet

The natural question is whether a record IPO year signals peak euphoria. Goldman’s analysis says the current environment falls short of bubble territory on three counts:

1. Deal count is normal. Roughly 100 IPOs projected for the full year, versus 250+ in 2021 and nearly 400 in 1999^[4].
2. Supply scales to the market. The $700 billion forecast represents about 1% of total equity market capitalization—below the long-term average^[4].
3. Corporate demand remains large. Buybacks exceeding $1 trillion should outweigh corporate supply of shares^[4].

Goldman’s IPO Barometer—a composite of interest rates, CEO confidence, and equity valuations—reads 140 against a long-term average of 100, which is elevated but below the 2021 peak^[4]. The quality distinction matters: unlike the dot-com era, today’s IPOs are dominated by large, revenue-generating companies rather than pre-profit speculative issuers.

The honest uncertainty, though, is in the 2027 picture. As Snider acknowledged, “the math does get harder in 2027” because today’s IPOs launched with relatively small floats, and lockup expirations will release far more supply over time^[4].

The H2 Pipeline: Narrowing but Consequential

The second-half pipeline is thinner than the first but carries outsized weight:

• Anthropic confidentially filed its S-1 on June 1 and is targeting an October listing at a valuation approaching $965 billion^[8]. Prediction markets price the probability of a 2026 listing at roughly 75%^[2].
• OpenAI filed on June 8 at a target valuation near $1 trillion but is reportedly weighing a delay into 2027, partly linked to SpaceX’s underwhelming post-IPO price action^[2].
• Databricks has explicitly ruled out a 2026 listing amid the crowded slate; 2027 is now consensus^[2].

A July correction in AI-related equities shaved approximately 18% off private market marks, narrowing the IPO window and forcing underwriters to revise preliminary valuation ranges for at least four planned listings^[8]. The window is not closed, but it has tightened.

What to Watch Next

The base case, drawing on Goldman’s framework, is that 2026’s supply is absorbable: buybacks exceed $1 trillion, new issuance is ~1% of market cap, and deal count sits near the historical average. I’d put that at roughly 65/35. The 35% is where it gets interesting. If Alphabet’s buyback halt proves to be a template rather than an anomaly—if other mega-cap technology companies redirect repurchase cash into AI capex and begin issuing equity to fund it—the demand cushion shrinks precisely as the supply wave from lockup expirations crests in 2027. That is the scenario where multiple compression, not just index-level volatility, enters the conversation.

For now, the market’s plumbing is handling the flow. The first real stress test arrives on August 6.